Clinical trials
Withdrawn Observational trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
143 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 3 |
| 2009 | 2 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 4 |
| 2015 | 8 |
| 2016 | 8 |
| 2017 | 5 |
| 2018 | 11 |
| 2019 | 14 |
| 2020 | 18 |
| 2021 | 19 |
| 2022 | 14 |
| 2023 | 10 |
| 2024 | 6 |
| 2025 | 5 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 143 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 24 |
| Centre Hospitalier Universitaire, Amiens | 13 |
| Hospices Civils de Lyon | 8 |
| Centre Hospitalier Universitaire de Nīmes | 7 |
| Centre Hospitalier Universitaire de Nice | 6 |
| University Hospital, Lille | 6 |
| Fondation Ophtalmologique Adolphe de Rothschild | 4 |
| University Hospital, Toulouse | 4 |
| Institut Bergonié | 3 |
| Nantes University Hospital | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 10 |
| Diabetes Mellitus | 5 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Ankylosis | 2 |
| Arthritis | 2 |
| Arthritis, Rheumatoid | 2 |
| Breast Neoplasms | 2 |
| Carcinoma, Hepatocellular | 2 |
| Cerebral Palsy | 2 |
| Choroidal Neovascularization | 2 |
Trials
Showing 1 to 25 of 143. Each trial links to its page on Pharma Observatory.
43 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.